Nasdaq Surf News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Surface Oncology (NASDAQ:SURF – Get Free Report) and Eastgate Biotech (OTCMKTS:ETBI – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, profitability, dividends and earnings. Profitability This table compares Surface Oncology and Eastgate […]

Surface Oncology (NASDAQ:SURF – Get Free Report) and Eastgate Biotech (OTCMKTS:ETBI – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk. Analyst Recommendations This is a breakdown of current […]

Surface Oncology, Inc. (NASDAQ:SURF – Get Free Report) was the target of a large decrease in short interest in the month of June. As of June 30th, there was short interest totalling 448,400 shares, a decrease of 44.6% from the June 15th total of 809,000 shares. Based on an average daily volume of 673,300 shares, […]

Surface Oncology, Inc. (NASDAQ:SURF – Get Rating) – Research analysts at HC Wainwright lifted their FY2027 EPS estimates for shares of Surface Oncology in a report released on Friday, May 5th. HC Wainwright analyst S. Ramakanth now expects that the company will post earnings of $0.21 per share for the year, up from their prior […]

Susquehanna International Group LLP boosted its stake in shares of Surface Oncology, Inc. (NASDAQ:SURF – Get Rating) by 108.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 49,815 shares of the company’s stock after buying an additional 25,903 shares during the period. Susquehanna International Group […]